Abbott Laboratories (ABT)

Income Statement
Quarterly Data

Difficulty: Beginner

The income statement presents information on the financial results of a company’s business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Abbott Laboratories, Consolidated Income Statement (quarterly data)

USD $ in millions

	3 months ended	Mar 31, 2019		Dec 31, 2018		Sep 30, 2018		Jun 30, 2018		Mar 31, 2018		Dec 31, 2017		Sep 30, 2017		Jun 30, 2017		Mar 31, 2017		Dec 31, 2016		Sep 30, 2016		Jun 30, 2016		Mar 31, 2016		Dec 31, 2015		Sep 30, 2015		Jun 30, 2015		Mar 31, 2015		Dec 31, 2014		Sep 30, 2014		Jun 30, 2014		Mar 31, 2014
	Net sales
	Cost of products sold, excluding amortization of intangible assets
	Amortization of intangible assets
	Gross profit
	Research and development
	Selling, general and administrative
	Operating earnings (loss)
	Interest expense
	Interest income
	Net foreign exchange gain (loss)
	Net loss on extinguishment of debt
	Other income (expense), net
	Earnings (loss) from continuing operations before tax
	Tax (expense) benefit on earnings from continuing operations
	Earnings (loss) from continuing operations
	Earnings (loss) from discontinued operations, net of tax
	Gain (loss) on sale of discontinued operations, net of tax
	Net earnings (loss) from discontinued operations, net of tax
	Net earnings (loss)

Item	Description	The company
Net sales	Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.	Abbott Laboratories’s net sales increased from Q3 2018 to Q4 2018 but then declined significantly from Q4 2018 to Q1 2019.
Operating earnings (loss)	The net result for the period of deducting operating expenses from operating revenues.	Abbott Laboratories’s operating earnings (loss) increased from Q3 2018 to Q4 2018 but then declined significantly from Q4 2018 to Q1 2019.
Earnings (loss) from continuing operations before tax	Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.	Abbott Laboratories’s earnings (loss) from continuing operations before tax increased from Q3 2018 to Q4 2018 but then declined significantly from Q4 2018 to Q1 2019.
Net earnings (loss)	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Abbott Laboratories’s net earnings (loss) increased from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.

	Abbott Laboratories	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

Abbott Laboratories (ABT)

Income StatementQuarterly Data

Income Statement
Quarterly Data